Answers are grounded in this paper and cite their sources.
Key Points A continued monoclonal protein response after ASCT in the absence of further therapy is prognostic in MM patients.
No takes yet. Share an insight, caveat, or question.
Gonsalves et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: